Sujal M Patel insider trades
Open-market stock purchases and sales by Sujal M Patel, CEO, President, and Secretary at Nautilus Biotechnology, Inc, from SEC Form 4 filings since Jan 14, 2010.
Track record: 25% of 16 scored buys are up 5% or more since purchase, averaging +31%.